RodneyJayEllisMDFACRO

Gynecologic Cancer, Skin Cancer, Urologic Cancer

Vice-Chair Clinical Operations Professor University South Florida Morsani College of Medicine Co-Chair Renal Rask Force NCI Principle Investigator NRG GU-005 Phase III Trial for Image Guided IMRT vs SBRT for Intermediate Risk Prostate Cancer

Join to view full profile

Dr. Ellis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ellis' full profile

Already have an account?

Office
2 Tampa General Cir
Fl 3
Tampa, FL 33606
Phone+1 813-844-7585

Summary

I am a dedicated Genito-Urinary Oncologist and certificate holder for a Focused Practice in Brachytherapy by the American Board of Radiology. I am an active member of the NRG GU Steering Committee and an internationally recognized Clinical Trialist with a focus on Advanced Image Guided Radiation Oncology for both molecular imaging and MRI functional imaging for prostate cancer as well as Renal Stereotactic Ablative Body Radiotherapy. I currently serve as a Co-Chair for the Renal Task Force for the NCI to help develop concepts for submission prior to approval by the NCI and CTEP. I have served on the NCCN panels for Prostate, Renal, and Elderly Oncology previously in prior positions to help formulate treatment guidelines for these patient populations.

Education & Training

Ohio State University HospitalResidency, Radiation Oncology, 1993 - 1996
Akron General Medical Center/NEOMEDInternship, Internal Medicine, 1992 - 1993
Northeast Ohio Medical UniversityClass of 1992

Certifications & Licensure

OH State Medical License 1993 - 2027
FL State Medical License 2014 - 2026
PA State Medical License 2019 - 2022
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Fellow American College of Radiation Oncology ACRO, 2008

Clinical Trials

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2011 Jul 01
Active, not recruiting
Phase 3
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer Start of enrollment: 2016 Feb 16
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
National Patterns of Early Adoption of Magnetic Resonance Imaging-Guided Linear Accelerators in 2018 to 2019.
James B Yu, Connor J Kinslow, Simon K Cheng, Rodney J Ellis, David P Horowitz
Advances in Radiation Oncology. 2023-01-09
45 citations
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International ...
Shankar Siva, Muhammad Ali, Rohann J M Correa, Alexander Muacevic, Lee Ponsky
The Lancet. Oncology. 2022-12-01
Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. T...
Rohann J M Correa, Alexander V Louie, Nicholas G Zaorsky, Eric J Lehrer, Rodney Ellis
European Urology Focus. 2021-03-01

Press Mentions

Hershey Medical Center Uses MRI-Guided Radiation Therapy to Attack CancerJune 29th, 2021
Hershey Medical Center and Penn State College of Medicine See Growth, ChangeSeptember 11th, 2019
Augmenix to Unveil New Clinical Data on Its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation OncologySeptember 20th, 2017